|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q42854801
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010715.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q42854801
|
|
024
|
|
|
‡a
0000-0002-1315-3204
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q42854801
|
|
046
|
|
|
‡s
19000000
|
|
100
|
0 |
|
‡a
Alison O'Brien
‡c
investigadora
‡9
ast
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Alison O'Brien
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Alison O'Brien
‡c
investigadora
‡9
es
|
|
400
|
0 |
|
‡a
Alison D. O'Brien
‡c
chercheuse
‡9
fr
|
|
400
|
0 |
|
‡a
Alison O'Brien
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A novel murine infection model for Shiga toxin-producing Escherichia coli
|
|
670
|
|
|
‡a
Author's A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.
|
|
670
|
|
|
‡a
Author's A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
|
|
670
|
|
|
‡a
Author's Activation of Shiga toxin type 2d
|
|
670
|
|
|
‡a
Author's Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer
|
|
670
|
|
|
‡a
Author's Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli.
|
|
670
|
|
|
‡a
Author's Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli
|
|
670
|
|
|
‡a
Author's Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections
|
|
670
|
|
|
‡a
Author's Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.
|
|
670
|
|
|
‡a
Author's Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli
|
|
670
|
|
|
‡a
Author's Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity
|
|
670
|
|
|
‡a
Author's Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
|
|
670
|
|
|
‡a
Author's Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7.
|
|
670
|
|
|
‡a
Author's Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli.
|
|
670
|
|
|
‡a
Author's Comparative Pathogenicity of Escherichia coli O157 and Intimin-Negative Non-O157 Shiga Toxin-Producing E. coli Strains in Neonatal Pigs
|
|
670
|
|
|
‡a
Author's Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity
|
|
670
|
|
|
‡a
Author's Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci.
|
|
670
|
|
|
‡a
Author's Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis
|
|
670
|
|
|
‡a
Author's Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function.
|
|
670
|
|
|
‡a
Author's Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice
|
|
670
|
|
|
‡a
Author's Dementia caregiver intervention research: in search of clinical significance
|
|
670
|
|
|
‡a
Author's Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis
|
|
670
|
|
|
‡a
Author's Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆
|
|
670
|
|
|
‡a
Author's Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease
|
|
670
|
|
|
‡a
Author's ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1
|
|
670
|
|
|
‡a
Author's ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE CYTOTOXIN
|
|
670
|
|
|
‡a
Author's Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits.
|
|
670
|
|
|
‡a
Author's Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells
|
|
670
|
|
|
‡a
Author's Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli
|
|
670
|
|
|
‡a
Author's Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
|
|
670
|
|
|
‡a
Author's Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.
|
|
670
|
|
|
‡a
Author's Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
|
|
670
|
|
|
‡a
Author's Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans
|
|
670
|
|
|
‡a
Author's Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames
|
|
670
|
|
|
‡a
Author's Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor.
|
|
670
|
|
|
‡a
Author's Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice
|
|
670
|
|
|
‡a
Author's Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice
|
|
670
|
|
|
‡a
Author's Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.
|
|
670
|
|
|
‡a
Author's Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody
|
|
670
|
|
|
‡a
Author's Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection
|
|
670
|
|
|
‡a
Author's Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature
|
|
670
|
|
|
‡a
Author's Mutations in hns reduce the adherence of Shiga toxin-producing E. coli 091:H21 strain B2F1 to human colonic epithelial cells and increase the production of hemolysin
|
|
670
|
|
|
‡a
Author's Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
|
|
670
|
|
|
‡a
Author's New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli
|
|
670
|
|
|
‡a
Author's Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.
|
|
670
|
|
|
‡a
Author's One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage
|
|
670
|
|
|
‡a
Author's Overview and Historical Perspectives
|
|
670
|
|
|
‡a
Author's Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora
|
|
670
|
|
|
‡a
Author's Pathogenesis of Shiga-toxin producing escherichia coli.
|
|
670
|
|
|
‡a
Author's Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers.
|
|
670
|
|
|
‡a
Author's Production of a Shiga-like cytotoxin by Campylobacter
|
|
670
|
|
|
‡a
Author's Production of Shiga-Like Toxin by Escherichia coli
|
|
670
|
|
|
‡a
Author's Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II
|
|
670
|
|
|
‡a
Author's Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2)
|
|
670
|
|
|
‡a
Author's PURIFICATION OF SHIGELLA DYSENTERIAE 1
|
|
670
|
|
|
‡a
Author's PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS
|
|
670
|
|
|
‡a
Author's Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay.
|
|
670
|
|
|
‡a
Author's Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
|
|
670
|
|
|
‡a
Author's Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
|
|
670
|
|
|
‡a
Author's Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response
|
|
670
|
|
|
‡a
Author's Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933.
|
|
670
|
|
|
‡a
Author's Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.
|
|
670
|
|
|
‡a
Author's Shiga-like toxin production from Escherichia coli associated with calf diarrhoea
|
|
670
|
|
|
‡a
Author's Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.
|
|
670
|
|
|
‡a
Author's Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles
|
|
670
|
|
|
‡a
Author's Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a
|
|
670
|
|
|
‡a
Author's Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastase
|
|
670
|
|
|
‡a
Author's Shiga Toxins: Potent Poisons, Pathogenicity Determinants, and Pharmacological Agents.
|
|
670
|
|
|
‡a
Author's Statement on scientific publication and security.
|
|
670
|
|
|
‡a
Author's Statement on the consideration of biodefence and biosecurity
|
|
670
|
|
|
‡a
Author's Structure of shiga toxin type 2
|
|
670
|
|
|
‡a
Author's Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.
|
|
670
|
|
|
‡a
Author's The economic impact of work and family issues: child care satisfaction and financial considerations of employed mothers
|
|
670
|
|
|
‡a
Author's The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins
|
|
670
|
|
|
‡a
Author's The Salmonella typhimurium flgM gene, which encodes a negative regulator of flagella synthesis and is involved in virulence, is present and functional in other Salmonella species
|
|
670
|
|
|
‡a
Author's Two domains of cytotoxic necrotizing factor type 1 bind the cellular receptor, laminin receptor precursor protein.
|
|
670
|
|
|
‡a
Author's Uncensored exchange of scientific results
|
|
670
|
|
|
‡a
Author's Vaccination of pregnant dams with intimin
|
|
670
|
|
|
‡a
Author's Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection
|
|
670
|
|
|
‡a
Author's Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models
|
|
670
|
|
|
‡a
Author's Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce.
|
|
670
|
|
|
‡a
Author's When a healthy diet turns deadly
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 2004043504
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000116475826
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/55921578
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|n 98005993
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|05973888X
|
|
909
|
|
|
‡a
(orcid) 0000000213153204
‡9
1
|
|
919
|
|
|
‡a
reducedtoxicityofshigatoxinstxtype2cinmicecomparedtostx2disassociatedwithinstabilityofstx2cholotoxin
‡A
Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
‡9
1
|
|
919
|
|
|
‡a
salmonellatyphimuriumtranslocatesflagellinacrossintestinalepitheliainducingaproinflammatoryresponse
‡A
Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response
‡9
1
|
|
919
|
|
|
‡a
shigaliketoxinconvertingphageofenterohemorrhagicescherichiacolistrain933
‡A
Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933.
‡9
1
|
|
919
|
|
|
‡a
shigaliketoxinconvertingphagesfromescherichiacolistrainsthatcausehemorrhagiccolitisorinfantilediarrhea
‡A
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.
‡9
1
|
|
919
|
|
|
‡a
shigaliketoxinproductionfromescherichiacoliassociatedwithcalfdiarrhoea
‡A
Shiga-like toxin production from Escherichia coli associated with calf diarrhoea
‡9
1
|
|
919
|
|
|
‡a
shigatoxinofenterohemorrhagicescherichiacolitypeo157h7promotesintestinalcolonization
‡A
Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.
‡9
1
|
|
919
|
|
|
‡a
shigatoxinproducingescherichiacoliinmontanabacterialgenotypesandclinicalprofiles
‡A
Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles
‡9
1
|
|
919
|
|
|
‡a
shigatoxinstxtype1areducestheoraltoxicityofstxtype2a
‡A
Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a
‡9
1
|
|
919
|
|
|
‡a
shigatoxintype2dactdisplaysincreasedbindingtoglobotriaosylceramideinvitroandincreasedlethalityinmiceafteractivationbyelastase
‡A
Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastase
‡9
1
|
|
919
|
|
|
‡a
shigatoxinspotentpoisonspathogenicitydeterminantsandpharmacologicalagents
‡A
Shiga Toxins: Potent Poisons, Pathogenicity Determinants, and Pharmacological Agents.
‡9
1
|
|
919
|
|
|
‡a
statementonscientificpublicationandsecurity
‡A
Statement on scientific publication and security.
‡9
1
|
|
919
|
|
|
‡a
statementontheconsiderationofbiodefenceandbiosecurity
‡A
Statement on the consideration of biodefence and biosecurity
‡9
1
|
|
919
|
|
|
‡a
structureofshigatoxintype2
‡A
Structure of shiga toxin type 2
‡9
1
|
|
919
|
|
|
‡a
structureofshigatoxintype2stx2fromescherichiacolio157h7
‡A
Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.
‡9
1
|
|
919
|
|
|
‡a
economicimpactofworkandfamilyissueschildcaresatisfactionandfinancialconsiderationsofemployedmothers
‡A
The economic impact of work and family issues: child care satisfaction and financial considerations of employed mothers
‡9
1
|
|
919
|
|
|
‡a
pathogenicmechanismsofshigatoxinandtheshigaliketoxins
‡A
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins
‡9
1
|
|
919
|
|
|
‡a
salmonellatyphimuriumflgmgenewhichencodesanegativeregulatorofflagellasynthesisandisinvolvedinvirulenceispresentandfunctionalinothersalmonellaspecies
‡A
The Salmonella typhimurium flgM gene, which encodes a negative regulator of flagella synthesis and is involved in virulence, is present and functional in other Salmonella species
‡9
1
|
|
919
|
|
|
‡a
2domainsofcytotoxicnecrotizingfactortype1bindthecellularreceptorlamininreceptorprecursorprotein
‡A
Two domains of cytotoxic necrotizing factor type 1 bind the cellular receptor, laminin receptor precursor protein.
‡9
1
|
|
919
|
|
|
‡a
uncensoredexchangeofscientificresults
‡A
Uncensored exchange of scientific results
‡9
1
|
|
919
|
|
|
‡a
vaccinationofpregnantdamswithintimin
‡A
Vaccination of pregnant dams with intimin
‡9
1
|
|
919
|
|
|
‡a
vaccinationofpregnantdamswithintimino157protectssucklingpigletsfromescherichiacolio157h7infection
‡A
Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection
‡9
1
|
|
919
|
|
|
‡a
virulenceoftheshigatoxintype2expressingescherichiacolio104h4germanoutbreakisolatein2animalmodels
‡A
Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models
‡9
1
|
|
919
|
|
|
‡a
virulencepotentialofactivatableshigatoxin2dproducingescherichiacoliisolatesfromfreshproduce
‡A
Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce.
‡9
1
|
|
919
|
|
|
‡a
whenahealthydietturnsdeadly
‡A
When a healthy diet turns deadly
‡9
1
|
|
919
|
|
|
‡a
bacilluscereusg9241makesanthraxtoxinandcapsulelikehighlyvirulentbanthracisamesbutbehaveslikeattenuatedtoxigenicnonencapsulatedbanthracissterneinrabbitsandmice
‡A
Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
‡9
1
|
|
919
|
|
|
‡a
bacillusanthracisexosporiumproteinbclaaffectssporegerminationinteractionwithextracellularmatrixproteinsandhydrophobicity
‡A
Bacillus anthracis exosporium protein BclA affects spore germination, interaction with extracellular matrix proteins, and hydrophobicity
‡9
1
|
|
919
|
|
|
‡a
antimicrobialeffectsofinterferoninducible190chemokinesagainstbacillusanthracissporesandbacilli
‡A
Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli
‡9
1
|
|
919
|
|
|
‡a
antibodyagainstthecarboxylterminusofintiminalphareducesenteropathogenicescherichiacoliadherencetotissueculturecellsandsubsequentinductionofactinpolymerization
‡A
Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.
‡9
1
|
|
919
|
|
|
‡a
antibodiestointiminandescherichiacolisecretedproteinsaandbinpatientswithenterohemorrhagicescherichiacoliinfections
‡A
Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections
‡9
1
|
|
919
|
|
|
‡a
antibodiesagainsthemolysinandcytotoxicnecrotizingfactortype1cnf1reducebladderinflammationinamousemodelofurinarytractinfectionwithtoxigenicuropathogenicescherichiacoli
‡A
Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli
‡9
1
|
|
919
|
|
|
‡a
adherenceandcolonizationmechanismsofenteropathogenicandenterohemorrhagicescherichiacoli
‡A
Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli.
‡9
1
|
|
919
|
|
|
‡a
activationofshigatoxintype2dstx2dbyelastaseinvolvescleavageofthe100terminal2aminoacidsofthea2peptideinthecontextoftheappropriatebpentamer
‡A
Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer
‡9
1
|
|
919
|
|
|
‡a
activationofshigatoxintype2d
‡A
Activation of Shiga toxin type 2d
‡9
1
|
|
919
|
|
|
‡a
singleaminoacidsubstitutionintheenzymaticdomainofcytotoxicnecrotizingfactortype1ofescherichiacolialtersthetissueculturephenotypetothatofthedermonecrotictoxinofbordetellaspp
‡A
A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
‡9
1
|
|
919
|
|
|
‡a
plantbasedoralvaccinetoprotectagainstsystemicintoxicationbyshigatoxintype2
‡A
A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.
‡9
1
|
|
919
|
|
|
‡a
novelmurineinfectionmodelforshigatoxinproducingescherichiacoli
‡A
A novel murine infection model for Shiga toxin-producing Escherichia coli
‡9
1
|
|
919
|
|
|
‡a
dementiacaregiverinterventionresearchinsearchofclinicalsignificance
‡A
Dementia caregiver intervention research: in search of clinical significance
‡9
1
|
|
919
|
|
|
‡a
comparisonsofnativeshigatoxinsstxstype1and2withchimerictoxinsindicatethatthesourceofthebindingsubunitdictatesdegreeoftoxicity
‡A
Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity
‡9
1
|
|
919
|
|
|
‡a
controlofnaturalresistancetosalmonellatyphimuriumandleishmaniadonovaniinmicebycloselylinkedbutdistinctgeneticloci
‡A
Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci.
‡9
1
|
|
919
|
|
|
‡a
developmentofahybridshigaholotoxoidvaccinetoelicitheterologousprotectionagainstshigatoxinstypes1and2
‡A
Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆
‡9
1
|
|
919
|
|
|
‡a
cellsurfacelocalizednucleolinisaeukaryoticreceptorfortheadhesinintimingammaofenterohemorrhagicescherichiacolio157h7
‡A
Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7.
‡9
1
|
|
919
|
|
|
‡a
defectinmacrophageeffectorfunctionconferssalmonellatyphimuriumsusceptibilityonc3hhejmice
‡A
Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice
‡9
1
|
|
919
|
|
|
‡a
cytotoxicnecrotizingfactortype1deliveredbyoutermembranevesiclesofuropathogenicescherichiacoliattenuatespolymorphonuclearleukocyteantimicrobialactivityandchemotaxis
‡A
Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis
‡9
1
|
|
919
|
|
|
‡a
detectionofepithelialcellinjuryandquantificationofinfectioninthehct8organoidmodelofcryptosporidiosis
‡A
Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis
‡9
1
|
|
919
|
|
|
‡a
environmentalandhumanisolatesofvibriocholeraeandvibrioparahaemolyticusproduceashigelladysenteriae1
‡A
ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1
‡9
1
|
|
919
|
|
|
‡a
comparativepathogenicityofescherichiacolio157andintiminnegativenono157shigatoxinproducingecolistrainsinneonatalpigs
‡A
Comparative Pathogenicity of Escherichia coli O157 and Intimin-Negative Non-O157 Shiga Toxin-Producing E. coli Strains in Neonatal Pigs
‡9
1
|
|
919
|
|
|
‡a
cloningofshigaliketoxinstructuralgenesfromatoxinconvertingphageofescherichiacoli
‡A
Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli.
‡9
1
|
|
919
|
|
|
‡a
cytotoxicnecrotizingfactortype1productionbyuropathogenicescherichiacolimodulatespolymorphonuclearleukocytefunction
‡A
Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function.
‡9
1
|
|
919
|
|
|
‡a
dietarychoiceaffectsshigatoxinproducingescherichiacolisteco157h7colonizationanddisease
‡A
Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease
‡9
1
|
|
919
|
|
|
‡a
environmentalandhumanisolatesofvibriocholeraeandvibrioparahaemolyticusproduceashigelladysenteriae1shigalikecytotoxin
‡A
ENVIRONMENTAL AND HUMAN ISOLATES OF VIBRIO CHOLERAE AND VIBRIO PARAHAEMOLYTICUS PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE CYTOTOXIN
‡9
1
|
|
919
|
|
|
‡a
escherichiacolio157h7infectionindutchbeltedandnewzealandwhiterabbits
‡A
Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits.
‡9
1
|
|
919
|
|
|
‡a
evaluationoftheroleofshigaandshigaliketoxinsinmediatingdirectdamagetohumanvascularendothelialcells
‡A
Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells
‡9
1
|
|
919
|
|
|
‡a
ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli
‡A
Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli
‡9
1
|
|
919
|
|
|
‡a
genetictoxoidsofshigatoxintypes1and2protectmiceagainsthomologousbutnotheterologoustoxinchallenge
‡A
Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
‡9
1
|
|
919
|
|
|
‡a
hemolysinofuropathogenicescherichiacolievokesextensivesheddingoftheuroepitheliumandhemorrhageinbladdertissuewithinthe124hoursafterintraurethralinoculationofmice
‡A
Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.
‡9
1
|
|
919
|
|
|
‡a
humanintestinaltissueandculturedcoloniccellscontainglobotriaosylceramidesynthasemrnaandthealternateshigatoxinreceptorglobotetraosylceramide
‡A
Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
‡9
1
|
|
919
|
|
|
‡a
identificationandcharacterizationofshigatoxintype2variantsinescherichiacoliisolatesfromanimalsfoodandhumans
‡A
Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans
‡9
1
|
|
919
|
|
|
‡a
immunizationofmicewithformalininactivatedsporesfromavirulentbacilluscereusstrainsprovidessignificantprotectionfromchallengewithbacillusanthracisames
‡A
Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames
‡9
1
|
|
919
|
|
|
‡a
intimintypesalphabetaandgammabindtonucleolinwithequivalentaffinitybutloweraviditythantothetranslocatedintiminreceptor
‡A
Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor.
‡9
1
|
|
919
|
|
|
‡a
macrophagedefectandinflammatorycellrecruitmentdysfunctioninsalmonellasusceptiblec3hhejmice
‡A
Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice
‡9
1
|
|
919
|
|
|
‡a
mappingofgeneticlocithatmodulatedifferentialcolonizationbyescherichiacolio157h7tuv862inadvancedrecombinantinbredbxdmice
‡A
Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice
‡9
1
|
|
919
|
|
|
‡a
monoclonalantibody11e10whichneutralizesshigatoxintype2stx2recognizes3regionsonthestx2asubunitblockstheenzymaticactionofthetoxininvitroandalterstheoverallcellulardistributionofthetoxin
‡A
Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.
‡9
1
|
|
919
|
|
|
‡a
mousemodelofhemolyticuremicsyndromecausedbyendotoxinfreeshigatoxin2stx2andprotectionfromlethaloutcomebyantistx2antibody
‡A
Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody
‡9
1
|
|
919
|
|
|
‡a
mousemodelsofescherichiacolio157h7infectionandshigatoxininjection
‡A
Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection
‡9
1
|
|
919
|
|
|
‡a
multicenterevaluationofasequencebasedprotocolforsubtypingshigatoxinsandstandardizingstxnomenclature
‡A
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature
‡9
1
|
|
919
|
|
|
‡a
mutationsinhnsreducetheadherenceofshigatoxinproducingecoli091h21strainb2f1tohumancolonicepithelialcellsandincreasetheproductionofhemolysin
‡A
Mutations in hns reduce the adherence of Shiga toxin-producing E. coli 091:H21 strain B2F1 to human colonic epithelial cells and increase the production of hemolysin
‡9
1
|
|
919
|
|
|
‡a
neutralizingantibodiestoshigatoxintype2stx2reducecolonizationofmicebystx2expressingescherichiacolio157h7
‡A
Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
‡9
1
|
|
919
|
|
|
‡a
newtherapeuticdevelopmentsagainstshigatoxinproducingescherichiacoli
‡A
New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli
‡9
1
|
|
919
|
|
|
‡a
novel3dimensionalorganoidmodelforevaluationoftheinteractionofuropathogenicescherichiacoliwithterminallydifferentiatedhumanurothelialcells
‡A
Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.
‡9
1
|
|
919
|
|
|
‡a
1of2copiesofthegenefortheactivatableshigatoxintype2dinescherichiacolio91h21strainb2f1isassociatedwithaninduciblebacteriophage
‡A
One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage
‡9
1
|
|
919
|
|
|
‡a
overviewandhistoricalperspectives
‡A
Overview and Historical Perspectives
‡9
1
|
|
919
|
|
|
‡a
pathogenesisofescherichiacolio157h7strain8624followingoralinfectionofbalb100micewithanintactcommensalflora
‡A
Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora
‡9
1
|
|
919
|
|
|
‡a
pathogenesisofshigatoxinproducingescherichiacoli
‡A
Pathogenesis of Shiga-toxin producing escherichia coli.
‡9
1
|
|
919
|
|
|
‡a
phase1safetyandpharmacokineticstudyofchimericmurinehumanmonoclonalantibody100alphastx2administeredintravenouslytohealthyadultvolunteers
‡A
Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers.
‡9
1
|
|
919
|
|
|
‡a
productionofashigalikecytotoxinbycampylobacter
‡A
Production of a Shiga-like cytotoxin by Campylobacter
‡9
1
|
|
919
|
|
|
‡a
productionofshigaliketoxinbyescherichiacoli
‡A
Production of Shiga-Like Toxin by Escherichia coli
‡9
1
|
|
919
|
|
|
‡a
purificationandsomepropertiesofaverotoxinfromahumanstrainofescherichiacolithatisimmunologicallyrelatedtoshigaliketoxin2
‡A
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II
‡9
1
|
|
919
|
|
|
‡a
purificationandsomepropertiesofaverotoxinfromahumanstrainofescherichiacolithatisimmunologicallyrelatedtoshigaliketoxin2vt2
‡A
Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2)
‡9
1
|
|
919
|
|
|
‡a
purificationofshigelladysenteriae1
‡A
PURIFICATION OF SHIGELLA DYSENTERIAE 1
‡9
1
|
|
919
|
|
|
‡a
purificationofshigelladysenteriae1shigaliketoxinfromescherichiacoli0157h7strainassociatedwithhaemorrhagiccolitis
‡A
PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS
‡9
1
|
|
919
|
|
|
‡a
rapiddetectionofshigatoxinproducingescherichiacolibyopticalimmunoassay
‡A
Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay.
‡9
1
|
|
919
|
|
|
‡a
recombinantexosporiumproteinbclaofbacillusanthracisiseffectiveasaboosterformiceprimedwithsuboptimalamountsofprotectiveantigen
‡A
Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BAV|495_219874
|
|
996
|
|
|
‡2
NII|DA15561544
|
|
996
|
|
|
‡2
LC|nb2008012557
|
|
996
|
|
|
‡2
ISNI|0000000385050375
|
|
996
|
|
|
‡2
PLWABN|9811492632705606
|
|
996
|
|
|
‡2
BIBSYS|14041144
|
|
996
|
|
|
‡2
BNE|XX6082412
|
|
996
|
|
|
‡2
LC|no2010083325
|
|
996
|
|
|
‡2
LC|n 98024315
|
|
996
|
|
|
‡2
N6I|vtls002761291
|
|
996
|
|
|
‡2
ISNI|0000000116475826
|
|
996
|
|
|
‡2
LC|no2020048529
|
|
996
|
|
|
‡2
BIBSYS|90065136
|
|
996
|
|
|
‡2
N6I|vtls000079845
|
|
996
|
|
|
‡2
J9U|987007315480105171
|
|
997
|
|
|
‡a
1900 0 flourished 0000 0
‡9
1
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
NUKAT|n 2004043504
‡3
suggested
‡3
viafid
‡3
title: (0.72, 'escherichiacolio157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
ISNI|0000000116475826
‡3
suggested
|
|
998
|
|
|
‡a
O'Brien, Alison D.,
‡2
SUDOC|05973888X
‡3
suggested
‡3
title: (0.67, 'escherichiacoli0157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
BIBSYS|7012478
‡3
viafid
‡3
title: (0.72, 'escherichiacolio157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
J9U|987007328392505171
‡3
suggested
‡3
title: (0.67, 'escherichiacoli0157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
LC|n 98005993
‡3
suggested
‡3
title: (0.72, 'escherichiacolio157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
|
998
|
|
|
‡a
O'Brien, Alison D.
‡2
CAOONL|ncf11320871
‡3
title: (0.67, 'escherichiacoli0157h7andothershigatoxinproducingecolistrains', 'ferretsasamodelsystemforrenaldiseasesecondarytointestinalinfectionwithescherichiacolio157h7andothershigatoxinproducingecoli')
|
